Sculptor Capital’s Tevogen Inc. Common Stock TVGN Stock Holding History

Sculptor Capital’s Portfolio TVGN Stock Details TVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-12,645	Closed	-$6.53M	–	650
2022 Q4	$6.53M	Buy	12,645 +2,689	+27%	+$1.38M	0.11%	206
2022 Q3	$5.05M	Hold	9,956	–	–	0.06%	362
2022 Q2	$4.98M	Buy	9,956 +2,653	+36%	+$1.33M	0.05%	411
2022 Q1	$3.65M	Buy	+7,303	New	+$3.63M	0.03%	506

Other funds holding TVGN

CCP

Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return

FCM

FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sculptor Capital's TVGN Position: Q1 2023 in Review

Sculptor Capital sold out of Tevogen Inc. Common Stock (TVGN) in Q1 2023, closing a stake of 12,645 shares — an estimated $6.53M sold.

Sculptor Capital first reported a position in TVGN in Q1 2022 and held it in 4 quarters. The position peaked at $6.53M in Q4 2022. 4 funds tracked by Wall St. Rank hold TVGN as of Q1 2023.

Sculptor Capital reported no remaining Tevogen Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Sculptor Capital sold 12,645 Tevogen Inc. Common Stock shares in Q1 2023, an estimated $6.53M.
Sculptor Capital first reported a position in Tevogen Inc. Common Stock in Q1 2022 and held it in 4 quarters.
Sculptor Capital's Tevogen Inc. Common Stock position peaked at $6.53M in Q4 2022.
4 funds tracked by Wall St. Rank held Tevogen Inc. Common Stock as of Q1 2023.

Based on Sculptor Capital's 13F filing for Q1 2023, filed 16 May 2023.